PTCT FY 2020 Earnings — PTC Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

PTCTPTC Therapeutics, Inc.

$5B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$381M+24.0% YoY

Gross Profit

$362M95.0% margin

Operating Income

-$432M-113.4% margin

Net Income

-$438M-115.1% margin

EPS (Diluted)

$-6.64

Cash Flow

Operating Cash Flow

-$194M

Free Cash Flow

-$250M

Stock-Based Comp.

$70M

Balance Sheet

Total Assets

$2.2B

Total Liabilities

$1.7B

Stockholders' Equity

$482M

Cash & Equivalents

$209M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$381M	$307M	+24.0%
Gross Profit	$362M	$295M	+22.7%
Operating Income	-$432M	-$241M	-79.0%
Net Income	-$438M	-$252M	-74.2%